Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Appoints Thijs Spoor as Chief Executive Officer

Established leader with nearly 30 years of combined executive, broad management and capital markets expertise across healthcare and medical device industriesCORALVILLE, IA / ACCESSWIRE / February 22, 2022

Related Keywords

Toronto ,Ontario ,Canada ,Thijs Spoor ,Jenene Thomas ,Kostenloser Wertpapierhandel ,Azurrx Biopharma ,Francesl Johnson ,Oliver Wyman ,Michael Schultz ,University Of Toronto ,Jp Morgan ,Credit Suisse ,Life Sciences ,Viewpoint Molecular Targeting Inc ,Company Melanoma ,Columbia Business School ,Viewpoint Molecular Targeting ,Chief Executive ,Chief Science Officer ,Viewpoint Molecular ,Fluoropharma Medical ,Wall Street ,Columbia Business ,Molecular Targeting ,Neuroendocrine Tumor ,Viewpoint ,Olecular ,Targeting ,Ppoints ,Sthijs ,Poor ,Chief ,Executive ,Officer ,